Timothy Daley
Stock Analyst at Wells Fargo
(2.04)
# 3,064
Out of 5,056 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $44.35 | +5.25% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $6.63 | +201.66% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $93.06 | +2.08% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $42.66 | +68.78% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $143.84 | +0.81% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,396.45 | -6.91% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $376.63 | -24.33% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $225.51 | +9.53% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $162.53 | +69.20% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $259.81 | +3.92% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $5.92 | +372.97% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $20.84 | +67.95% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $576.03 | -9.73% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.86 | +949.69% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $153.06 | +20.87% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $74.11 | +14.69% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $217.28 | +1.25% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $161.02 | +36.63% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $11.14 | +151.35% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $185.32 | -24.46% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $58.15 | +54.77% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $44.35
Upside: +5.25%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $6.63
Upside: +201.66%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $93.06
Upside: +2.08%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $42.66
Upside: +68.78%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $143.84
Upside: +0.81%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,396.45
Upside: -6.91%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $376.63
Upside: -24.33%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $225.51
Upside: +9.53%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $162.53
Upside: +69.20%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $259.81
Upside: +3.92%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $5.92
Upside: +372.97%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $20.84
Upside: +67.95%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $576.03
Upside: -9.73%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.86
Upside: +949.69%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $153.06
Upside: +20.87%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $74.11
Upside: +14.69%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $217.28
Upside: +1.25%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $161.02
Upside: +36.63%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $11.14
Upside: +151.35%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $185.32
Upside: -24.46%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $58.15
Upside: +54.77%